What is the address of DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE?

The registered office of DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE is located at Maaldestedestraat 58, 8902 Ieper.

Is DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 March 2002; 5 annual accounts filed, latest fiscal year 2025.

What is the revenue of DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE?

As a small company, DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 354,014.

DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE

Q: Is DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE still active?

Yes. According to the CBE (15 November 2026) DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE is active, legal situation “Normale toestand”, started on 18 March 2002.

Q: Is DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE registered on Peppol?

Yes, DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE is registered on the Peppol network with ID 0208:0477111821.

Q: What is the enterprise number of DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE?

The enterprise number of DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE is BE0477111821.

Q: When was DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE founded?

DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE was founded on 18 March 2002.

Q: How much profit did DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE make in 2025?

DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE posted a profit after taxes of € 245,083 in financial year 2025.

Dossier DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE, printed on 15 November 2026 from databakkes.be/en/0477111821/dokter-jan-creupelandt-anesthesie-en-urgentiegeneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE from Ieper, company number BE0477111821, closed financial year 2025 with a result of € 245,083 after tax. For that financial year DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE recorded a gross margin of € 354,014 and equity of € 931,768. Compared with financial year 2024, the result moved from € 253,200 to € 245,083. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 29, 2026.

What it is worth Growing

€ 931,768

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 245,083

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 249,331

▲ 82% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 144,234 paid out

59 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,380

▲ 119% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 65,282

▲ 81% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 190,547 Gross margin 2022: € 190,547 First fiscal year in the series	€ 333,406 Gross margin 2023: € 333,406 ▲ 75% vs 2022 (€ 190,547) Favourable step	€ 361,178 Gross margin 2024: € 361,178 ▲ 8% vs 2023 (€ 333,406) Favourable step	€ 354,014 Gross margin 2025: € 354,014 ▼ 2% vs 2024 (€ 361,178) Unfavourable step	▼ 2%
Profit after taxes	€ 130,865 Profit after taxes 2022: € 130,865 First fiscal year in the series	€ 226,713 Profit after taxes 2023: € 226,713 ▲ 73% vs 2022 (€ 130,865) Favourable step	€ 253,200 Profit after taxes 2024: € 253,200 ▲ 12% vs 2023 (€ 226,713) Favourable step	€ 245,083 Profit after taxes 2025: € 245,083 ▼ 3% vs 2024 (€ 253,200) Unfavourable step	▼ 3%
Equity	€ 500,306 Equity 2022: € 500,306 First fiscal year in the series	€ 687,718 Equity 2023: € 687,718 ▲ 37% vs 2022 (€ 500,306) Favourable step	€ 830,919 Equity 2024: € 830,919 ▲ 21% vs 2023 (€ 687,718) Favourable step	€ 931,768 Equity 2025: € 931,768 ▲ 12% vs 2024 (€ 830,919) Favourable step	▲ 12%
Total debts	€ 41,767 Total debts 2022: € 41,767 First fiscal year in the series	€ 68,492 Total debts 2023: € 68,492 ▲ 64% vs 2022 (€ 41,767) Unfavourable step	€ 44,544 Total debts 2024: € 44,544 ▼ 35% vs 2023 (€ 68,492) Favourable step	€ 73,376 Total debts 2025: € 73,376 ▲ 65% vs 2024 (€ 44,544) Unfavourable step	▲ 65%
Cash	€ 359,671 Cash 2022: € 359,671 First fiscal year in the series	€ 330,384 Cash 2023: € 330,384 ▼ 8% vs 2022 (€ 359,671) Unfavourable step	€ 137,248 Cash 2024: € 137,248 ▼ 58% vs 2023 (€ 330,384) Unfavourable step	€ 249,331 Cash 2025: € 249,331 ▲ 82% vs 2024 (€ 137,248) Favourable step	▲ 82%
Retained profit	€ 388,306 Retained profit 2022: € 388,306 First fiscal year in the series	€ 575,718 Retained profit 2023: € 575,718 ▲ 48% vs 2022 (€ 388,306) Favourable step	€ 828,919 Retained profit 2024: € 828,919 ▲ 44% vs 2023 (€ 575,718) Favourable step	€ 929,768 Retained profit 2025: € 929,768 ▲ 12% vs 2024 (€ 828,919) Favourable step	▲ 12%
Dividend	€ 23,227 Dividend 2022: € 23,227 First fiscal year in the series	€ 39,300 Dividend 2023: € 39,300 ▲ 69% vs 2022 (€ 23,227) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 39,300) Unchanged	€ 144,234 Dividend 2025: € 144,234 Unchanged (€ 0) Unchanged
Balance sheet total	€ 542,073 Balance sheet total 2022: € 542,073 First fiscal year in the series	€ 756,210 Balance sheet total 2023: € 756,210 ▲ 40% vs 2022 (€ 542,073) Unchanged	€ 875,463 Balance sheet total 2024: € 875,463 ▲ 16% vs 2023 (€ 756,210) Unchanged	€ 1,005,143 Balance sheet total 2025: € 1,005,143 ▲ 15% vs 2024 (€ 875,463) Unchanged	▲ 15%

By gross margin, DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE ranks 3rd of 4 companies with main activity “Activiteiten van medisch specialisten” in Ieper that publish figures (fiscal year 2025).

Key figures of DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE?

What happened at DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 29, 2026 New annual accounts for financial year 2025: profit of € 245,083 (▼ 3% vs 2024). Source: NBB ↗
Mar 18, 2002 New establishment in Ieper. KBO
Mar 18, 2002 Start of the company according to the CBE. KBO

In short

From € 130,865 profit in 2022 to € 245,083 profit in 2025.

Paid € 400,811 in corporate taxes since 2022.

Best year ever: 2024, with € 253,200 profit.

Paid out € 206,762 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Maaldestedestraat 58

8902 Ieper

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Ieper

Same main activity (Activiteiten van medisch specialisten), 3 active companies in Ieper, largest first.

Dr. O. BROUCKAERT

€ 686,343 gross margin · 2025

Dr. Evert Matthys MKA

€ 638,158 gross margin · 2025

ACpath

€ 301,339 gross margin · 2025

All companies with this activity → Largest companies in Ieper →

Details

Company number: 0477.111.821
VAT number: BE 0477.111.821
Registered office: Maaldestedestraat 58, 8902 Ieper
Names & denominations: DOKTER JAN CREUPELANDT ANESTHESIE EN URGENTIEGENEESKUNDE · DR. J. CREUPELANDT
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 March 2002
Peppol: Active · Active since 21 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗